BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Alpelisib

Alpelisib [Supplementary Concept]

227+ PubMed studies analyzed · 14 RCTs · Evidence Score: 48.2

Research Domains

Alpelisib has been studied across 9 research domains including 🔬 Oncology, 🧬 Hormones, 🔥 Metabolic, ⏳ Longevity & Aging, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 53% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Alpelisib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

voxtalisib
5 shared targets
buparlisib
6 shared targets
sapanisertib
5 shared targets
zstk
5 shared targets
gedatolisib
5 shared targets
pf
5 shared targets
copanlisib
5 shared targets
vistusertib
5 shared targets
vs
5 shared targets
duvelisib
4 shared targets
Loading evidence profile...

This evidence profile for Alpelisib is generated deterministically from 227 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.